All In MedTech

FDA Clearance Tracker · P120016-S024

VASCADE MVP Venous Vascular Closure System (VVCS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 27, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P120016-S024
Device name
VASCADE MVP Venous Vascular Closure System (VVCS)
Applicant location
Santa Clara, CA
Received
May 30, 2018
Decided
Nov 27, 2018
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P120016

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

Approval for percutaneous closure of femoral venous access sites while reducing time to ambulation, total post-procedure time, time to hemostasis, and time to discharge eligibility in patients who have undergone catheter-based procedures utilizing 6-12F inner diameter procedural sheaths, with single or multiple access sites in one or both limbs.

Source documents

Other decisions for Cardiva Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.